To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

First-Dose Tolerability of Tramadol-Celecoxib Co-Crystal vs Tramadol in Acute Pain

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2025

First-Dose Tolerability of Tramadol-Celecoxib Co-Crystal vs Tramadol in Acute Pain

Vol: 307| Issue: 9| Number:9| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Adverse Reactions Following First-Dose Administration of Co-Crystal of Tramadol-Celecoxib Versus Tramadol Alone for Moderate-To-Severe Acute Pain.

Pain Ther . 2025 Jun;14(3):1147-1154.

Contributing Authors:
A Morte M Sust A Vaqué J Cebrecos JM Giménez-Arnau

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Three hundred sixty-six patients with moderate-to-severe acute postoperative pain following first metatarsal osteotomy were analyzed after receiving a first dose of CTC 200 mg (n=183) or tramadol 50 mg (n=183). The pupose was to provide a descriptive snapshot of first-dose tolerability. The primary outcome of interest for this post-hoc analysis was the prevalence of study drug–related, opioid-asso...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue